Visualase Cooled Laser Applicator System (VCLAS). The VCLAS system consists of the Visualase Las...
FDA Device Recall #Z-1672-2016 — Class II — May 9, 2016
Recall Summary
| Recall Number | Z-1672-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 9, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medtronic Navigation, Inc. |
| Location | Louisville, CO |
| Product Type | Devices |
| Quantity | 120 |
Product Description
Visualase Cooled Laser Applicator System (VCLAS). The VCLAS system consists of the Visualase Laser Diffusing Fiber (LDF) and the Visualase Cooled Catheter System (CCS). The LDF and disposables (including the CCS) is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy in medicine and surgery in cardiovascular thoracic surgery (excluding the heart and the vessels of the pericardial sac), dermatology, ear-nose-throat surgery, gastroenterology, general surgery, gynecology, head and neck surgery, neurosurgery, plastic surgery, pulmonology, radiology and urology.
Reason for Recall
Potential for the Visualase Cooled Laser Applicator System (VCLAS) catheters to melt during procedures.
Distribution Pattern
Distributed within the US, Netherlands, Canada and Australia and to govt/VA/military consignees.
Lot / Code Information
All lot numbers manufactured by BioTex are affected for Model Numbers: T03: 001-4003 - VCLAS 001-4003 .4mm CORE FIBER 3mm TIP T10: 001-4000 - VCLAS 001-4000 .4mm CORE FIBER 10mm TIP T15: 001-6000 - VCLAS 001-6000 .6mm CORE FIBER 15mm TIP
Other Recalls from Medtronic Navigation, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1022-2025 | Class II | Medtronic PIN, 100mm STERILE PERCUTANEOUS REF: ... | Dec 4, 2024 |
| Z-0050-2025 | Class II | StealthStation S8 App versions 1.3.0 and 1.3.2,... | Aug 22, 2024 |
| Z-1776-2024 | Class I | Stealth S8 Clinical Software Application, REF: ... | Mar 26, 2024 |
| Z-0698-2024 | Class II | Medtronic, REF 9733235, Pin, 100mm, STERILE, PE... | Nov 28, 2023 |
| Z-0699-2024 | Class II | Medtronic, REF 9733236, Pin, 150mm, STERILE, PE... | Nov 28, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.